Latest News and Press Releases

For immediate release iSTAR Medical’s MINIject® demonstrates significant sustained 5-year efficacy in treating glaucoma in STAR-GLOBAL trial Five-year safety profile including corneal health...

For immediate release iSTAR Medical’s MINIject® demonstrates significant sustained 5-year efficacy in treating glaucoma in STAR-GLOBAL trial Five-year safety profile including corneal health...

For immediate release iSTAR Medical continues to strengthen US presence with appointment of Chief Medical Officer and Vice President of Clinical Affairs WAVRE, Belgium — 4 September 2024: iSTAR...

For immediate release iSTAR Medical Expands International Commercial Rollout of MINIject® with Successful First Implants Completed in Australia WAVRE, Belgium — 10 January 2024: iSTAR Medical, a...

For immediate release iSTAR Medical continues European expansion with first MINIject® surgeries in the Netherlands WAVRE, Belgium — 22 December 2023: iSTAR Medical, a medtech company delivering...

For immediate release iSTAR Medical conducts first MINIject® surgeries in Ireland, expanding commercial rollout in Europe WAVRE, Belgium — 31 October 2023: iSTAR Medical, a medtech company...

For immediate release iSTAR Medical presents positive three-year results for MINIject® from STAR-GLOBAL trial Interim three-year follow-up data further demonstrate consistent safety and efficacy of...

MINIject® is the only commercially available MIGS implant targeting the supraciliary space Clinical data show positive, consistent results up to two-year follow-up in patients across Europe, Asia, and...

For immediate release iSTAR Medical Expands Commercial Rollout of MINIject with First Surgeries in Sweden and Norway The only commercially available MIGS device currently targeting the supraciliary...

For immediate release iSTAR Medical Presents Positive Consistent Results for MINIject® Across Three International Glaucoma Trials Analysis provides further validation of MINIject®’s meaningful and...